442.     Zacest AC, Besser M, Stevens G, Thompson JF, McCarthy WH, Culjak G. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 2002;96:552-8.

441.     Thompson JF, Shaw HM. The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome? Ann Surg Oncol 2002;9:719-22.

440.     Thompson JF. The blue dye isotope technique. In: Cody H, ed. Sentinel Lymph Node Biopsy. London: Martin Dunitz Ltd; 2002:113-20.

439.     Tattersall MH, Butow PN, Brown JE, Thompson JF. Improving doctors' letters. Med J Aust 2002;177:516-20.

438.     Shaw HM, Thompson JF. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 2002;9:934;author reply -5.

437.     Shaw HM, McCarthy WH, Scolyer RA. Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis. Cancer 2002;95:671-2; author reply 2-3.

436.     Shaw H, Thompson J. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma. Cancer 2002;94:283-4.

435.     Menzies SW. Dermoscopy of pigmented basal cell carcinoma. Clin Dermatol 2002;20:268-9.

434.     McCarthy WH. Melanoma: Margins for error -- another view. ANZ J Surg 2002;72:304-6.

433.     Lindner P, Doubrovsky A, Kam PC, Thompson JF. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma. Ann Surg Oncol 2002;9:127-36.

432.     Hersey P, Coates AS, McCarthy WH, Thompson JF, Sillar RW, McLeod R, Gill PG, Coventry BJ, McMullen A, Dillon H, Simes RJ. Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trial. J Clin Oncol 2002;20:4181-90.

431.     Hanrahan PF, D'Este CA, Menzies SW, Plummer T, Hersey P. A randomised trial of skin photography as an aid to screening skin lesions in older males. J Med Screen 2002;9:128-32.

430.     Balch CM, Soong SJ, Thompson JF, Buzaid AC. Prognostic factors and staging of melanoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Progress in Oncology. Massachusetts: Jones and Bartlett; 2002:214-50.